跳至主要内容
临床试验/ACTRN12620001250921
ACTRN12620001250921已完成未知

Role of naturally occurring dietary salicylates in Irritable Bowel Syndrome: Investigating impact on gastrointestinal symptoms

Monash University0 个研究点目标入组 10 人开始时间: 2020年11月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Patients with irritable bowel syndrome based on Rome III criteria.

排除标准

  • - coeliac disease
  • - pregnancy and breastfeeding,
  • - other significant co-morbid conditions such as diabetes and inflammatory bowel disease.
  • - previously received advice or information on a low chemical diet.
  • - taking pharmacological agents like laxatives to alter their symptoms.
  • - taking aspirin or any other drugs containing or delivering salicylates for at least two weeks prior to the commencement of the study.

研究者

相似试验